Summary
For Year 2026-27, Sai Parenteral's reports the following shareholding: Total Promoters at 51.16%, Mutual Fund at 3.81%, Insurance at 2.89%, Foreign Institutional Investors at 5.73%, Domestic Institutional Investors at 6.16%, and Retail at 30.26%. This breakdown provides a quick snapshot of ownership distribution for Sai Parenteral's in 2026-27.
Sai Parenteral's FAQs
As of 04-2026, the promoter shareholding in Sai Parenteral's stands at 51.16% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sai Parenteral's is 5.73% and 6.16% respectively.
The retail shareholding of the Sai Parenteral's is 30.26%.
Changes in shareholding patterns of Sai Parenteral's can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sai Parenteral's are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
